Literature DB >> 14550470

Quantitative RT-PCR assay for MUC3 and VEGF mRNA in renal clear cell carcinoma: relationship with nuclear grade and prognosis.

Xavier Leroy1, Valerie Gouyer, Charles Ballereau, Farid Zerimech, Guillemette Huet, Marie-Christine Copin, Jean-Pierre Aubert, Nicole Porchet.   

Abstract

OBJECTIVES: To investigate, by real-time quantitative reverse transcriptase-polymerase chain reaction, the expression of MUC3 and vascular endothelial growth factor (VEGF) to correlate them with histologic parameters and with prognosis. Human mucins are large O-glycoproteins expressed in epithelial tissues. Deregulation of mucin genes has been demonstrated in several epithelial neoplasms. In the kidney, MUC3 is expressed in normal convoluted tubules and in renal clear cell carcinoma.
METHODS: Twenty-six renal clear cell carcinoma specimens were studied. For all tumors, samples of normal and tumor kidney were frozen. After RNA extraction, using ultracentrifugation through a cesium chloride cushion, VEGF and MUC3 mRNA were analyzed by real-time quantitative reverse transcriptase-polymerase chain reaction. The pathologic parameters included Fuhrman nuclear grade and TNM stage. All follow-up data were available.
RESULTS: The median level of MUC3 and VEGF expression was greater in tumor areas compared with normal areas (P < 0.002 and P < 0.001, respectively). The MUC3 tumor/normal tissue expression ratio was greater in nuclear grade 3 tumor than in low grades (grade 1-2; P < 0.005). No statistically significant relationship was found with the prognosis for MUC3 and VEGF in our study.
CONCLUSIONS: The results of this study demonstrate that MUC3 and VEGF are overexpressed in renal clear cell carcinoma, and the MUC3 expression ratio is greater in nuclear grade 3 than in grades 1 and 2 (low grades) tumor. These findings suggest the implication of MUC3 in renal carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14550470     DOI: 10.1016/s0090-4295(03)00560-0

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  4 in total

1.  Epigenetic regulation of mucin genes in human cancers.

Authors:  Norishige Yamada; Sho Kitamoto; Seiya Yokoyama; Tomofumi Hamada; Masamichi Goto; Hideaki Tsutsumida; Michiyo Higashi; Suguru Yonezawa
Journal:  Clin Epigenetics       Date:  2011-05-01       Impact factor: 6.551

2.  A comprehensive expression analysis of mucins in appendiceal carcinoma in a multicenter study: MUC3 is a novel prognostic factor.

Authors:  Hiroaki Shibahara; Michiyo Higashi; Seiya Yokoyama; Karine Rousseau; Iwao Kitazono; Masahiko Osako; Hiroshi Shirahama; Yukie Tashiro; Yasuhiro Kurumiya; Michihiko Narita; Shingo Kuze; Hiroshi Hasagawa; Takehito Kato; Hitoshi Kubota; Hideaki Suzuki; Toshiyuki Arai; Yu Sakai; Norihiro Yuasa; Masahiko Fujino; Shinji Kondo; Yoshichika Okamoto; Tatsuyoshi Yamamoto; Takashi Hiromatsu; Eiji Sasaki; Kazuhisa Shirai; Satoru Kawai; Koutarou Hattori; Hideki Tsuji; Osamu Okochi; Masaki Sakamoto; Akinobu Kondo; Naomi Konishi; Surinder K Batra; Suguru Yonezawa
Journal:  PLoS One       Date:  2014-12-31       Impact factor: 3.240

3.  The role of MUC1 and MUC3 in the biology and prognosis of colorectal cancer.

Authors:  Timothy J Duncan; Nicholas F S Watson; Ahmad H Al-Attar; John H Scholefield; Lindy G Durrant
Journal:  World J Surg Oncol       Date:  2007-03-09       Impact factor: 2.754

4.  Increased expression of MUC3A is associated with poor prognosis in localized clear-cell renal cell carcinoma.

Authors:  Tian Niu; Yidong Liu; Yuan Zhang; Qiang Fu; Zheng Liu; Zewei Wang; Hangcheng Fu; Jiejie Xu; Kun Liu
Journal:  Oncotarget       Date:  2016-08-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.